BrainStorm Cell Therapeutics (NASDAQ:BCLI) is a biotechnology company developing innovative, autologous stem cell therapies for highly debilitating neurodegenerative diseases such as Amyotrophic Lateral Sclerosis (ALS, also known as Lou Gehrig's diseas...

Biotechnology

Brainstorm Cell Therapeutics

Chaim Lebovits

Haro Hartounian

Antal Pearl-Lendner

Katia Lejnev

Arturo Araya

Ralph Kern

Eyal Rubin

Mary Kay Turner

Uri Yablonka

Yael Gothelf

Yossef Levy

Revital Aricha

Susan E. Ward

Alex Burshtein

The Research and Development Team at BrainStorm Cell Therapeutics focuses on pioneering autologous stem cell therapies aimed at treating debilitating neurodegenerative diseases such as ALS. The team combines advanced data science, cutting-edge research, and rigorous scientific methodologies to drive innovation and development from initial concept through clinical trials.

Research and Development Team

Leadership Team

Regulatory and Clinical Operations

Quality Control and Assurance

Research and Development Team

About

Team members

Other teams at Brainstorm Cell Therapeutics

Leadership Team

Regulatory and Clinical Operations

Quality Control and Assurance